BLUECHIIP LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.005 AUD | -16.67% |
|
-16.67% | -68.75% |
| May. 14 | Bluechiip, Biopharma Group Forge UK Distribution Partnership | MT |
| Feb. 29 | Bluechiip Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
| Sales 2024 * | 2.7M 1.8M | Sales 2025 * | 6.3M 4.19M | Capitalization | 6.6M 4.4M |
|---|---|---|---|---|---|
| Net income 2024 * | -4M -2.66M | Net income 2025 * | -1M -666K | EV / Sales 2024 * | 2.34 x |
| Net cash position 2024 * | 300K 200K | Net cash position 2025 * | 1.4M 932K | EV / Sales 2025 * | 0.83 x |
| P/E ratio 2024 * |
-1.2
x | P/E ratio 2025 * |
-6
x | Employees | - |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 66.73% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -16.67% | ||
| 1 week | -16.67% | ||
| Current month | -16.67% | ||
| 1 month | -28.57% | ||
| 3 months | -28.57% | ||
| 6 months | -75.00% | ||
| Current year | -68.75% |
1 week
0.01
0.01
1 month
0.010.01
Current year
0.010.02
1 year
0.010.03
3 years
0.010.07
5 years
0.010.20
10 years
0.010.22
| Managers | Title | Age | Since |
|---|---|---|---|
Andrew McLellan
CEO | Chief Executive Officer | - | - |
Chelsea Sheridan
SEC | Corporate Secretary | - | 22-01-09 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 60 | 14-12-14 | |
Iain Kirkwood
CHM | Chairman | 72 | 07-10-31 |
Andrew Cox
BRD | Director/Board Member | - | 17-07-25 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-06-04 | 0.005 | -16.67% | 26 400 |
| 24-05-31 | 0.006 | 0.00% | 597,200 |
| 24-05-30 | 0.006 | 0.00% | 44,252 |
| 24-05-28 | 0.006 | 0.00% | 66,619 |
Delayed Quote Australian S.E., June 04, 2024 at 08:00 pm EDT
More quotes
Bluechiip Limited is an Australia-based company, which is engaged in the development of advanced sample management solutions for harsh environments. The principal activity of the Company is the development and commercialization of a wireless tracking solution for the healthcare and life science, security, defense, and manufacturing industries. Its solutions include Bluechiip Enabled Solutions, Custom Solutions and Partnerships. The Company offers a range of services across product design, engineering and manufacturing. It also offers partners the ability to license its patented technology to differentiate their product and service offerings. The Company's Sample Storage solutions include Bluechiip Enabled CryoVial Range, Bluechiip Enabled CryoBoxes, Bluechiip Enabled CryoTags and a range of accessories for all advanced sample management needs. Its Readers solutions include Bluechiip Enabled Handheld Reader, Bluechiip Enabled Multivial Reader and Bluechiip Enabled CryoBox Tracker.
Calendar
2024-08-28
- Q4 2024 Earnings Release (Projected)
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -68.75% | 4.41M | |
| +7.32% | 217B | |
| +13.83% | 194B | |
| +20.48% | 143B | |
| +31.33% | 111B | |
| +3.08% | 64.3B | |
| +14.64% | 52.94B | |
| +2.72% | 49.53B | |
| -5.88% | 38.31B | |
| +0.25% | 35.22B |
- Stock Market
- Equities
- BCT Stock
